Anika Therapeutics Inc. (ANIK)
NASDAQ: ANIK
· Real-Time Price · USD
9.07
-0.05 (-0.55%)
At close: Oct 03, 2025, 3:59 PM
9.00
-0.77%
After-hours: Oct 03, 2025, 06:27 PM EDT
-0.55% (1D)
| Bid | 8.9 |
| Market Cap | 130.77M |
| Revenue (ttm) | 123.74M |
| Net Income (ttm) | -60.63M |
| EPS (ttm) | -0.9 |
| PE Ratio (ttm) | -10.08 |
| Forward PE | -16.29 |
| Analyst | Buy |
| Dividends | n/a |
| Ask | 9.94 |
| Volume | 219,748 |
| Avg. Volume (20D) | 125,100 |
| Open | 9.34 |
| Previous Close | 9.12 |
| Day's Range | 9.03 - 9.50 |
| 52-Week Range | 7.87 - 25.65 |
| Beta | 0.62 |
| Ex-Dividend Date | n/a |
About ANIK
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol ANIK
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for ANIK stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsAnika Therapeutics Inc. is scheduled to release its earnings on
Oct 30, 2025,
before market opens.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
2 months ago
-27.42%
Anika Therapeutics shares are trading lower after ...
Unlock content with
Pro Subscription
4 months ago
-21.03%
Anika Therapeutics shares are trading lower after the company reported mixed Q1 financial results.
2 months ago · seekingalpha.com
Anika Therapeutics, Inc. (ANIK) Q2 2025 Earnings Call TranscriptAnika Therapeutics, Inc. (NASDAQ:ANIK ) Q2 2025 Earnings Conference Call July 30, 2025 8:30 AM ET Company Participants Cheryl Renee Blanchard - President, CEO & Director Matt Hall - Corporate Particip...
